Public Health Global

Global Refractive Error and Spectacles Public Health Report

Updated Reviewed by Vidhi Upadhyay

Global Refractive Error and Spectacles Public Health Report: Disease Burden, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook

Public Health Dashboard · published data

Refractive Error and Spectacles worldwide: key statistics

Global
Latest published figures for the countries in this report
Country People aged 65 and overof peopleCataract operationsper 100,000 peopleHealth spending from abroadof health spending
Bangladesh 6.7% 2025 — 3.5% 2023
Egypt 5.3% 2025 — 3.5% 2023
Ethiopia 3.3% 2025 — 26.9% 2023
India 7.4% 2025 — 2.4% 2023
Kenya 3.0% 2025 — 20.1% 2023
Nigeria 3.1% 2025 — 11.3% 2023
Pakistan 4.4% 2025 — 9.7% 2023

Sources: World Bank, OECD Health Statistics. A dash means no recent published figure.

Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.

Buy the full report

Report snapshot

Global Refractive Error and Spectacles Public Health Report at a glance
TopicRefractive Error and Spectacles
PlaceGlobal
People aged 65 and over (latest)10.4% of people (2025)Source: World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
Report sections16 (table of contents)
Active clinical trials35 worldwideSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Global Refractive Error and Spectacles: Overview and Epidemiological Profile

Uncorrected refractive error, such as short-sight and needing reading glasses, is the leading cause of vision loss, and is fixed with glasses. This report covers myopia, presbyopia and other refractive error.

Burden: Prevalence, Incidence and Mortality

The report sets out the prevalence, incidence and, where relevant, deaths from refractive error and spectacles worldwide, and the overall burden, using Prevalence of Vision Loss and Blindness, Effective Cataract Surgery Coverage, Effective Refractive Error Coverage, Cataract Surgery Rate and Eye Care Workforce.

Demographic Distribution: Age, Gender and Vulnerable Population Groups

The burden is broken down by age (children 0–14 years, adults 15–49 years, adults 50–69 years and adults 70 years and over), gender and income, with a focus on older adults, children, rural residents, women, people with diabetes and low-income households.

Geographical Distribution: State, District, Urban and Rural Segmentation

Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.

Risk Factors and Social Determinants of Health

Main risk factors include ageing, diabetes, infections such as trachoma, UV and eye injuries, few eye care services and cost of glasses and surgery. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.

Awareness and Screening Coverage

The report reviews how aware people are of refractive error and spectacles and how far screening reaches them, through vision screening, school screening, rapid assessment of avoidable blindness (RAAB) and primary care checks, by group and by area.

Diagnosis Rates and Undiagnosed Burden

It compares the number of people diagnosed with the estimated number affected, to show the undiagnosed burden and how many people are lost between screening and treatment.

Treatment, Prevention and Coverage

Treatment and prevention covered include vision screening, low-cost ready-made spectacles, optometrist training and WHO SPECS 2030 initiative, with how many people receive treatment and how many stay on it.

Health Outcomes and Complications

Long-term effects covered include blindness and vision loss, lost education and work, falls and injuries and depression and isolation, along with other conditions that often occur alongside refractive error and spectacles.

Healthcare Infrastructure and Accessibility

The report looks at eye hospitals, outreach camps, ophthalmologists and optometrists and primary care, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.

Economic and Socioeconomic Burden

Refractive Error and Spectacles worldwide: health cover, spending and research

WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.⁠[1] The world scores 71 out of 100 on the WHO universal health coverage index (2023).⁠[2] People pay 17.3% of all health spending out of their own pockets (2023).⁠[3] ClinicalTrials.gov lists 35 studies on Refractive Error and Spectacles that are recruiting, active or about to start worldwide.⁠[4]

[1] World Health Organization, universal health coverage. Checked 14 Nov 2026.

[2] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 18 Nov 2026.

[3] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 18 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

It describes the costs of refractive error and spectacles to health systems and households, including out-of-pocket spending and lost productivity, and how government, donors and NGOs fund the response.

Government Initiatives and Public Health Interventions

Worldwide guidance and funding for refractive error and spectacles include WHO World Report on Vision, WHO SPECS 2030 Initiative, 2030 In Sight (IAPB) and World Health Assembly Eye Care Coverage Targets for 2030. The report reviews national programmes, donor and NGO funding, and what is known about their impact.

Historical Trends and Comparative Analysis

Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.

Healthcare Gaps and Unmet Needs

The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.

Future Burden and Public Health Outlook

It looks ahead at the likely future burden of refractive error and spectacles, the healthcare it will need and the areas most vulnerable.

Key Findings and Strategic Recommendations

The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from Rapid Assessment of Avoidable Blindness (RAAB), IAPB Vision Atlas, Global Burden of Disease (IHME) and National Eye Surveys. Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Refractive Error and Spectacles Public Health Report right now, from free public sources.

Clinical trials

35 active trials worldwide

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. SightGlass Vision, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Essilor International 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Refractive Error and Spectacles Public Health Report in context

Free data on this topic

Quick answers

Frequently asked questions

What are refractive error and spectacles?
Uncorrected refractive error, such as short-sight and needing reading glasses, is the leading cause of vision loss, and is fixed with glasses. This report covers myopia, presbyopia and other refractive error.
What does the report on refractive error and spectacles worldwide cover?
The report has 16 sections: overview and epidemiological profile; burden; demographic distribution; geographical distribution; risk factors and social determinants of health; awareness and screening coverage; diagnosis rates and undiagnosed burden; treatment, prevention and coverage; health outcomes and complications; healthcare infrastructure and accessibility; economic and socioeconomic burden; government initiatives and public health interventions; historical trends and comparative analysis; healthcare gaps and unmet needs; future burden and public health outlook; key findings and strategic recommendations.
How good is health coverage worldwide?
The world scores 71 out of 100 on the WHO universal health coverage index (2023). Source: WHO Global Health Observatory, Universal health coverage index. Retrieved 18 Nov 2026.
How much of health spending do people pay themselves worldwide?
People pay 17.3% of all health spending out of their own pockets (2023). Source: World Bank Open Data, Out-of-pocket spending. Retrieved 18 Nov 2026.
How is healthcare paid for worldwide?
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021. Source: World Health Organization, universal health coverage. Checked 14 Nov 2026.
How many clinical trials on refractive error and spectacles are running worldwide?
35 studies are recruiting, active or about to start worldwide, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
Back to Catalogue

Related Public Health reports in Global

See all

Related on eye health

See the topic